Galectins and Ovarian Cancer

被引:19
|
作者
Shimada, Chisa [1 ,2 ]
Xu, Rui [1 ,2 ]
Al-Alem, Linah [1 ,2 ]
Stasenko, Marina [3 ]
Spriggs, David R. [1 ,4 ]
Rueda, Bo R. [1 ,2 ,5 ]
机构
[1] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA
[2] Harvard Med Sch, Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[3] Mem Sloan Kettering Canc Ctr, Gynecol Serv, 1275 York Ave, New York, NY 10065 USA
[4] Massachusetts Gen Hosp, Dept Hematol Med Oncol, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Boston, MA 02114 USA
关键词
ovarian cancer; galectins; invasion; metastasis; chemoresistance; immune suppression; GALACTOSIDE-BINDING LECTIN; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR PROGRESSION; PROSTATE-CANCER; ELECTRIC ORGAN; CELL-MIGRATION; T-CELLS; APOPTOSIS; EXPRESSION; CARCINOMA;
D O I
10.3390/cancers12061421
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer is known for its aggressive pathological features, including the capacity to undergo epithelial to mesenchymal transition, promoting angiogenesis, metastatic potential, chemoresistance, inhibiting apoptosis, immunosuppression and promoting stem-like features. Galectins, a family of glycan-binding proteins defined by a conserved carbohydrate recognition domain, can modulate many of these processes, enabling them to contribute to the pathology of ovarian cancer. Our goal herein was to review specific galectin members identified in the context of ovarian cancer, with emphasis on their association with clinical and pathological features, implied functions, diagnostic or prognostic potential and strategies being developed to disrupt their negative actions.
引用
收藏
页数:28
相关论文
共 50 条
  • [41] Galectins and Gliomas
    Le Mercier, Marie
    Fortin, Shannon
    Mathieu, Veronique
    Kiss, Robert
    Lefranc, Florence
    BRAIN PATHOLOGY, 2010, 20 (01) : 17 - 27
  • [42] Introduction to galectins
    Leffler, H
    Carlsson, S
    Hedlund, M
    Qian, YN
    Poirier, F
    GLYCOCONJUGATE JOURNAL, 2002, 19 (7-9) : 433 - 440
  • [43] Galectins at a glance
    Johannes, Ludger
    Jacob, Ralf
    Leffler, Hakon
    JOURNAL OF CELL SCIENCE, 2018, 131 (09)
  • [44] Galectins-1,-3,-7,-8 and-9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis
    Pergialiotis, Vasilios
    Papoutsi, Eleni
    Androutsou, Anastasia
    Tzortzis, Andrianos-Serafeim
    Frountzas, Maximos
    Papapanagiotou, Angeliki
    Kontzoglou, Konstantinos
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 152 (03) : 299 - 307
  • [45] Characterization of the mechanisms underlying the crosstalk between galectins and notch in gastric cancer
    Sofia N Santos
    Celso Reis
    Marcelo Dias-Baruffi
    Roger Chammas
    Emerson S Bernardes
    BMC Proceedings, 7 (Suppl 2)
  • [46] Varied expression and localization of multiple galectins in different cancer cell lines
    Satelli, Arun
    Rao, Prema S.
    Gupta, Prem K.
    Lockman, Paul R.
    Srivenugopal, Kalkunte S.
    Rao, U. Subrahmanyeswara
    ONCOLOGY REPORTS, 2008, 19 (03) : 587 - 594
  • [47] Expression profiling of cancer-related galectins in acute myeloid leukemia
    El Leithy, Asmaa A.
    Helwa, Reham
    Assem, Magda M.
    Hassan, Nagwa H. A.
    TUMOR BIOLOGY, 2015, 36 (10) : 7929 - 7939
  • [48] Subtypes of Ovarian Cancer and Ovarian Cancer Screening
    Koshiyama, Masafumi
    Matsumura, Noriomi
    Konishi, Ikuo
    DIAGNOSTICS, 2017, 7 (01):
  • [49] Multifaceted roles of Galectins: from carbohydrate binding to targeted cancer therapy
    Zhang, Nan
    Liu, Qiao
    Wang, Daihan
    Wang, Xiaoyun
    Pan, Zhaoping
    Han, Bo
    He, Gu
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [50] Degraded Arabinogalactans and Their Binding Properties to Cancer-Associated Human Galectins
    Pfeifer, Lukas
    Baumann, Alexander
    Petersen, Lea Madlen
    Hoeger, Bastian
    Beitz, Eric
    Classen, Birgit
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)